Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 4 (April)

1. Identification of hypertension-related genes through an integrated genomic-transcriptomic approach.
   Circ Res, 96(6): 617-25. [Abstract] [Full-text]
2. Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations.
   Eur J Clin Nutr, 59(4): 480-8. [Abstract] [Full-text]
3. A thermodynamic model to predict the thermal response of living beings during pneumoperitoneum procedures.
   J Med Eng Technol, 29(2): 75-81. [Abstract] [Full-text]
4. Role of protein kinase C beta in phorbol ester-induced c-fos gene expression in neurons of normotensive and spontaneously hypertensive rat brains.
   Brain Res, 1040(1): 129-36. [Abstract] [Full-text]
5. Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension.
   Am J Hum Genet, 76(5): 815-32. [Abstract] [Full-text]
6. Genetics of human hypertension.
   Trends Endocrinol Metab, 16(3): 127-33. [Abstract] [Full-text]
7. Low renin hypertensive states: perspectives, unsolved problems, future research.
   Trends Endocrinol Metab, 16(3): 108-13. [Abstract] [Full-text]
8. Monogenic low renin hypertension.
   Trends Endocrinol Metab, 16(3): 92-7. [Abstract] [Full-text]
9. Plasma renin and aldosterone measurements in low renin hypertensive states.
   Trends Endocrinol Metab, 16(3): 86-91. [Abstract] [Full-text]
10. Regulators of angiogenesis in renal ischemia/reperfusion injury in normotensive and hypertensive rats: effect of tacrolimus.
    Transplant Proc, 37(1): 352-4. [Abstract] [Full-text]
11. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies.
    Ophthalmology, 112(4): 540-7. [Abstract] [Full-text]
12. Adrenomedullin gene delivery alleviates hypertension and its secondary injuries of cardiovascular system.
    Hum Gene Ther, 16(3): 372-80. [Abstract] [Full-text]
13. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
    JAMA, 293(13): 1595-608. [Abstract] [Full-text]
14. Does dietary recall adequately assess sodium, potassium, and calcium intake in hypertensive patients?
    Nutrition, 21(4): 462-6. [Abstract] [Full-text]
15. Pressure response to carotid occlusion in diabetic rats: effect of insulin therapy.
    Diabetes Res Clin Pract, 68(1): 12-7. [Abstract] [Full-text]
16. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Clin Ther, 27(2): 166-73. [Abstract] [Full-text]
17. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
    Diabetes Obes Metab, 7(3): 246-53. [Abstract] [Full-text]
18. Ganglion blockade does not prevent cortisol-induced hypertension in man.
    Clin Exp Pharmacol Physiol, 32(4): 294-6. [Abstract] [Full-text]
19. Losartan and simvastatin inhibit platelet activation in hypertensive patients.
    J Thromb Thrombolysis, 18(3): 177-85. [Abstract] [Full-text]
20. Cerebral white matter lesions and hypertension status in the elderly Korean: the Ansan Study.
    Arch Gerontol Geriatr, 40(3): 265-73. [Abstract] [Full-text]
21. Evaluation of drug therapy and risk factors in diabetic hypertensives: a study of the quality of care provided in diabetic clinics in Bahrain.
    J Eval Clin Pract, 11(2): 121-31. [Abstract] [Full-text]
22. Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period.
    Cerebrovasc Dis, 19(4): 253-9. [Abstract] [Full-text]
23. The 'geneticisation' of heart disease: a network analysis of the production of new genetic knowledge.
    Soc Sci Med, 60(12): 2673-83. [Abstract] [Full-text]
24. Decreased tyrosine hydroxylase activity in the adrenals of spontaneously hypertensive rats.
    Life Sci, 76(25): 2953-64. [Abstract] [Full-text]
25. Increased levels of CD40-CD40 ligand system in patients with essential hypertension.
    Clin Chim Acta, 355(1): 191-6. [Abstract] [Full-text]
26. Valsartan reduces interleukin-1beta secretion by peripheral blood mononuclear cells in patients with essential hypertension.
    Clin Chim Acta, 355(1): 131-6. [Abstract] [Full-text]
27. Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils.
    Clin Chim Acta, 355(1): 97-104. [Abstract] [Full-text]
28. Cardiac-specific effects of parathyroid hormone-related peptide: modification by aging and hypertension.
    Cardiovasc Res, 66(2): 334-44. [Abstract] [Full-text]
29. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension.
    Cardiovasc Res, 66(2): 307-17. [Abstract] [Full-text]
30. TGF-beta impairs renal autoregulation via generation of ROS.
    Am J Physiol Renal Physiol, 288(5): F1069-77. [Abstract] [Full-text]
31. Substitution of chromosome 1 ameliorates L-NAME hypertension and renal disease in the fawn-hooded hypertensive rat.
    Am J Physiol Renal Physiol, 288(5): F1015-22. [Abstract] [Full-text]
32. Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.
    Am J Physiol Renal Physiol, 288(5): F1044-52. [Abstract] [Full-text]
33. Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat.
    Am J Physiol Renal Physiol, 288(5): F1023-31. [Abstract] [Full-text]
34. Acute effects of automated continuous positive airway pressure on blood pressure in patients with sleep apnea and hypertension.
    Respiration, 72(2): 150-5. [Abstract] [Full-text]
35. Effect of exercise on blood pressure in older persons: a randomized controlled trial.
    Arch Intern Med, 165(7): 756-62. [Abstract] [Full-text]
36. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.
    Arch Intern Med, 165(7): 742-8. [Abstract] [Full-text]
37. Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.
    Blood Press, 14(1): 38-44. [Abstract] [Full-text]
38. The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patients.
    Blood Press, 14(1): 31-7. [Abstract] [Full-text]
39. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
    Blood Press, 14(1): 25-31. [Abstract] [Full-text]
40. Tumor necrosis factor and interleukin-6 levels in hypertensive patients with and without left ventricular hypertrophy.
    Blood Press, 14(1): 21-4. [Abstract] [Full-text]
41. Angiotensin-receptor blockers and diuretics--advantages of combination.
    Blood Press, 14(1): 6-11. [Abstract] [Full-text]
42. Interactive effects of avoidant coping and parental hypertension on rate pressure product reactivity in women.
    Ann Behav Med, 29(2): 106-15. [Abstract] [Full-text]
43. MORE--MOexipril and REgression of left ventricle hypertrophy in combination therapy A multicentric open label clinical trial.
    Int J Cardiol, 100(2): 199-206. [Abstract] [Full-text]
44. LDL cholesterol and global risk stratification in referred hypertensive patients.
    Atherosclerosis, 180(1): 137-43. [Abstract] [Full-text]
45. Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension.
    Heart, 91(5): 624-9. [Abstract] [Full-text]
46. Self-reported hypertension treatment beliefs and practices of primary care physicians in a managed care organization.
    Am J Hypertens, 18(4): 566-71. [Abstract] [Full-text]
47. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Am J Hypertens, 18(4): 557-65. [Abstract] [Full-text]
48. PPARgamma in endothelial cells influences high fat diet-induced hypertension.
    Am J Hypertens, 18(4): 549-56. [Abstract] [Full-text]
49. Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats.
    Am J Hypertens, 18(4): 538-43. [Abstract] [Full-text]
50. Association of interleukin-6 gene G-174C polymorphism and plasma plasminogen activator inhibitor-1 level in Chinese patients with and without hypertension.
    Am J Hypertens, 18(4): 517-22. [Abstract] [Full-text]
51. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Am J Hypertens, 18(4): 493-9. [Abstract] [Full-text]
52. Relation of genetic predisposition and insulin resistance to left ventricular hypertrophy in hypertension.
    Am J Hypertens, 18(4): 457-63. [Abstract] [Full-text]
53. Insulin resistance in men with treated hypertension at increased risk for cardiovascular disease: results of a 3-year study.
    Am J Hypertens, 18(4): 452-6. [Abstract] [Full-text]
54. Circadian blood pressure variation in morbidly obese hypertensive patients undergoing gastric bypass surgery.
    Am J Hypertens, 18(4): 446-51. [Abstract] [Full-text]
55. Patients' and general practitioners' views of what constitutes appropriate hypertension management.
    J Health Serv Res Policy, 10(2): 91-6. [Abstract] [Full-text]
56. Interactions of high salt intake and the response of the cardiovascular system to aldosterone.
    Cardiol Rev, 13(3): 118-24. [Abstract] [Full-text]
57. 5-HT in systemic hypertension: foe, friend or fantasy?
    Clin Sci (Lond), 108(5): 399-412. [Abstract] [Full-text]
58. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
    Kidney Blood Press Res, 28(2): 117-26. [Abstract] [Full-text]
59. Comparison of the effects of quinapril and losartan on carotid artery intima-media thickness in patients with mild-to-moderate arterial hypertension.
    Kidney Blood Press Res, 28(2): 111-6. [Abstract] [Full-text]
60. Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.
    Methods Find Exp Clin Pharmacol, 27(2): 119-25. [Abstract] [Full-text]
61. Effect of rofecoxib on antihypertensive effects of candesartan in experimental models of hypertension.
    Methods Find Exp Clin Pharmacol, 27(1): 11-6. [Abstract] [Full-text]
62. Effects of potassium adaptation on blood pressure and pressor responses in normotensive and renal hypertensive Wistar rats.
    Methods Find Exp Clin Pharmacol, 27(1): 5-10. [Abstract] [Full-text]
63. Association of cigarette smoking with steady-state plasma concentration of irbesartan in male Chinese with hypertension.
    Methods Find Exp Clin Pharmacol, 27(3): 173-8. [Abstract] [Full-text]
64. Genome-wide scans for heritability of fasting serum insulin and glucose concentrations in hypertensive families.
    Diabetologia, 48(4): 661-8. [Abstract] [Full-text]
65. Elevated serum uric acid levels in gestational hypertension are correlated with insulin resistance.
    Am J Perinatol, 22(3): 139-44. [Abstract] [Full-text]
66. Hyperventilation and amplified blood pressure response: is there a link?
    J Hum Hypertens, 19(5): 381-7. [Abstract] [Full-text]
67. Protecting renal function in the hypertensive patient: clinical guidelines.
    Am J Hypertens, 18(4): 112S-119S. [Abstract] [Full-text]
68. Preventing chronic kidney disease in special populations.
    Am J Hypertens, 18(4): 106S-111S. [Abstract] [Full-text]
69. The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease.
    Am J Hypertens, 18(4): 100S-105S. [Abstract] [Full-text]
70. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Am J Hypertens, 18(4): 95S-99S. [Abstract] [Full-text]
71. Thyrotropin-releasing hormone in cardiovascular pathophysiology.
    Regul Pept, 128(3): 239-46. [Abstract] [Full-text]
72. The left ventricle and hemodynamic patterns in essential hypertension.
    Regul Pept, 128(3): 221-5. [Abstract] [Full-text]
73. Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD).
    Contemp Clin Trials, 26(2): 211-22. [Abstract] [Full-text]
74. The veterans' study to improve the control of hypertension (V-STITCH): design and methodology.
    Contemp Clin Trials, 26(2): 155-68. [Abstract] [Full-text]
75. Spontaneously hypertensive rats left ventricular cardiomyocyte loss attenuation through different edible oils long-term intake.
    Int J Cardiol, 100(3): 461-6. [Abstract] [Full-text]
76. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients.
    J Intern Med, 257(5): 454-60. [Abstract] [Full-text]
77. Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma.
    J Exp Med, 201(8): 1217-28. [Abstract] [Full-text]
78. Efficacy and safety of prolonged amlodipine treatment in hypertensive children.
    Pediatr Nephrol, 20(5): 631-5. [Abstract] [Full-text]
79. Evaluation of the effect of candesartan cilexetil on the steady-state pharmacokinetics of tacrolimus in renal transplant patients.
    Biopharm Drug Dispos, 26(4): 135-41. [Abstract] [Full-text]
80. Transiently elevated diastolic blood pressure is associated with a gender-dependent effect on cardiovascular risk.
    J Hum Hypertens, 19(5): 347-54. [Abstract] [Full-text]
81. Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?
    J Hum Hypertens, 19(5): 331-9. [Abstract] [Full-text]
82. Effects of weight status on the recommendations of and adherence to lifestyle modifications among hypertensive adults.
    J Hum Hypertens, 19(5): 365-71. [Abstract] [Full-text]
83. Association of essential hypertension with a microsatellite marker on chromosome 17.
    J Hum Hypertens, 19(5): 407-11. [Abstract] [Full-text]
84. The long-term outcome of patients with hypertensive cardiomyopathy.
    J Hum Hypertens, 19(5): 393-400. [Abstract] [Full-text]
85. Neonatal renovascular hypertension due to prenatal traumatic retroperitoneal hematoma.
    Pediatr Nephrol, 20(5): 670-2. [Abstract] [Full-text]
86. Cancer pattern among hypertensive patients in North Karelia, Finland.
    J Hum Hypertens, 19(5): 373-9. [Abstract] [Full-text]
87. In hypertension, the kidney is not always the heart of the matter.
    J Clin Invest, 115(4): 840-4. [Abstract] [Full-text]
88. Level of acculturation and hypertension among Dallas County Hispanics: findings from the Dallas Heart Study.
    Ann Epidemiol, 15(5): 373-80. [Abstract] [Full-text]
89. Determinants of cardiorenal damage progression in normotensive and never-treated hypertensive subjects.
    Kidney Int, 67(5): 1974-9. [Abstract] [Full-text]
90. Modified TEI index: a promising parameter in essential hypertension?
    Echocardiography, 22(4): 296-304. [Abstract] [Full-text]
91. Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension.
    Eur Heart J, 26(9): 921-7. [Abstract] [Full-text]
92. Nitrite is an alternative source of NO in vivo.
    Am J Physiol Heart Circ Physiol, 288(5): H2163-70. [Abstract] [Full-text]
93. Sex differences in the development of angiotensin II-induced hypertension in conscious mice.
    Am J Physiol Heart Circ Physiol, 288(5): H2177-84. [Abstract] [Full-text]
94. Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle.
    Am J Physiol Heart Circ Physiol, 288(5): H2457-64. [Abstract] [Full-text]
95. Decreased Ca2+ extrusion via Na+/Ca2+ exchange in epicardial left ventricular myocytes during compensated hypertrophy.
    Am J Physiol Heart Circ Physiol, 288(5): H2431-8. [Abstract] [Full-text]
96. AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats.
    Am J Physiol Heart Circ Physiol, 288(5): H2289-97. [Abstract] [Full-text]
97. Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure.
    Am J Physiol Heart Circ Physiol, 288(5): H2118-22. [Abstract] [Full-text]
98. Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension.
    Am J Cardiol, 95(9): 1060-4. [Abstract] [Full-text]
99. Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients.
    Br J Clin Pharmacol, 59(5): 520-3. [Abstract] [Full-text]
100. The natural history of white coat hypertension during pregnancy.
     BJOG, 112(5): 601-6. [Abstract] [Full-text]
101. Maternal complications in women with chronic hypertension: a population-based cohort study.
     Acta Obstet Gynecol Scand, 84(5): 419-24. [Abstract] [Full-text]
102. Pheochromocytoma unmasked by amisulpride and tiapride.
     Ann Pharmacother, 39(5): 970-2. [Abstract] [Full-text]
103. Blood pressure in Native Americans switched from celecoxib to rofecoxib.
     Ann Pharmacother, 39(5): 797-802. [Abstract] [Full-text]
104. Programmed syndrome of hypernatremic hypertension in ovine twin lambs.
     Am J Obstet Gynecol, 192(4): 1196-204. [Abstract] [Full-text]
105. Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial.
     Transplant Proc, 37(2): 1245-7. [Abstract] [Full-text]
106. Fraxinus excelsior L. evokes a hypotensive action in normal and spontaneously hypertensive rats.
     J Ethnopharmacol, 99(1): 49-54. [Abstract] [Full-text]
107. The impact of co-morbid conditions on the SF-36: a primary-care-based study among hypertensives.
     Arch Med Res, 36(2): 136-41. [Abstract] [Full-text]
108. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
     Arch Intern Med, 165(8): 947-53. [Abstract] [Full-text]
109. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
     Arch Intern Med, 165(8): 936-46. [Abstract] [Full-text]
110. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
     Arch Intern Med, 165(8): 923-8. [Abstract] [Full-text]
111. Does hypertension protect against chronic musculoskeletal complaints? The Nord-Trøndelag Health Study.
     Arch Intern Med, 165(8): 916-22. [Abstract] [Full-text]
112. Free-breathing renal magnetic resonance angiography with steady-state free-precession and slab-selective spin inversion combined with radial k-space sampling and water-selective excitation.
     Magn Reson Med, 53(5): 1228-33. [Abstract] [Full-text]
113. Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study.
     Eur Heart J, 26(10): 1039-45. [Abstract] [Full-text]
114. Enhanced hypotensive effects of the essential oil of Ocimum gratissimum leaves and its main constituent, eugenol, in DOCA-salt hypertensive conscious rats.
     Planta Med, 71(4): 376-8. [Abstract] [Full-text]
115. Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats.
     Brain Res, 1042(2): 184-93. [Abstract] [Full-text]
116. Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists.
     Int J Clin Pract, 59(2): 214-24. [Abstract] [Full-text]
117. Heart failure from diastolic dysfunction related to hypertension: guidelines for management.
     J Am Acad Nurse Pract, 17(5): 168-75. [Abstract] [Full-text]
118. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
     Int J Clin Pract, 59(4): 478-84. [Abstract] [Full-text]
119. The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidaemic hypertensive patients.
     Int J Clin Pract, 59(4): 415-8. [Abstract] [Full-text]
120. Hypertensive emergency associated with thoracoabdominal aneurysm: case report and review.
     Pediatr Crit Care Med, 6(3): 359-62. [Abstract] [Full-text]
121. Withdrawal syndrome following cessation of antihypertensive drug therapy.
     Int J Clin Pract, 59(5): 562-70. [Abstract] [Full-text]
122. Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension.
     Int J Clin Pract, 59(3): 306-10. [Abstract] [Full-text]
123. Statins and hypertension.
     Semin Vasc Med, 4(4): 367-75. [Abstract] [Full-text]
124. Many little things: one geneticist's view of complex diseases.
     Nat Rev Genet, 6(5): 419-25. [Abstract] [Full-text]
125. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
     Int J Cardiol, 101(1): 97-104. [Abstract] [Full-text]
126. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
     Eur J Clin Invest, 35(5): 324-9. [Abstract] [Full-text]
127. Baroreflex failure.
     Hypertension, 45(5): 834-9. [Abstract] [Full-text]
128. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.
     Hypertension, 45(5): 934-9. [Abstract] [Full-text]
129. Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure.
     Hypertension, 45(5): 927-33. [Abstract] [Full-text]
130. Carvedilol reduces plasma 8-hydroxy-2'-deoxyguanosine in mild to moderate hypertension: a pilot study.
     Hypertension, 45(5): 986-90. [Abstract] [Full-text]
131. Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension.
     Hypertension, 45(5): 967-73. [Abstract] [Full-text]
132. Chloride-dominant salt sensitivity in the stroke-prone spontaneously hypertensive rat.
     Hypertension, 45(5): 867-73. [Abstract] [Full-text]
133. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome.
     Hypertension, 45(5): 907-13. [Abstract] [Full-text]
134. Diabetic brain damage in hypertension: role of renin-angiotensin system.
     Hypertension, 45(5): 887-93. [Abstract] [Full-text]
135. The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy.
     Hypertension, 45(5): 921-6. [Abstract] [Full-text]
136. Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension.
     Hypertension, 45(5): 880-6. [Abstract] [Full-text]
137. Klk1 as one of the genes contributing to hypertension in Dahl salt-sensitive rat.
     Hypertension, 45(5): 947-53. [Abstract] [Full-text]
138. Serum uric acid and target organ damage in primary hypertension.
     Hypertension, 45(5): 991-6. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.